Karyopharm Therapeutics Inc (KPTI)
NASDAQ
The current KPTI market cap is 89.15M. The company's latest EPS is USD -1.1477 and P/E is -0.64.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 33.58M | 38.7M | 37.58M | 36.01M | 33.75M |
Operating Income | -33.87M | -30.9M | -29.57M | -31.26M | -37.81M |
Net Income | -38.51M | -34.13M | -32.63M | -34.51M | -41.84M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 40.89M | 108.09M | 209.82M | 157.07M | 146.03M |
Operating Income | -189.28M | -171.85M | -98.27M | -142.2M | -129.54M |
Net Income | -199.59M | -196.27M | -124.09M | -165.29M | -143.1M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 358.17M | 325.8M | 297.83M | 269.96M | 240.44M |
Total Liabilities | 374.83M | 370.97M | 369.08M | 370.36M | 376.64M |
Total Equity | -16.66M | -45.17M | -71.25M | -100.4M | -136.21M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 294.96M | 313.05M | 305.31M | 358.17M | 240.44M |
Total Liabilities | 245.19M | 262.5M | 384.98M | 374.83M | 376.64M |
Total Equity | 49.77M | 50.55M | -79.67M | -16.66M | -136.21M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -149.55M | -18.91M | -44.61M | -74.14M | -92.72M |
Investing | -104.26M | -32.39M | -11.22M | -18.9M | 7.94M |
Financing | 193.74M | N/A | 860k | 860k | 1.12M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -190.82M | -160.23M | -107.12M | -149.55M | -92.72M |
Investing | 78.45M | -53.69M | 141.84M | -104.26M | 7.94M |
Financing | 124.31M | 172.08M | 73.65M | 193.74M | 1.12M |
Market Cap | 89.15M |
Price to Earnings Ratio | -0.64 |
Price to Sales Ratio | 0.63 |
Price to Cash Ratio | 1.77 |
Price to Book Ratio | -0.68 |
Dividend Yield | - |
Shares Outstanding | 124.68M |
Average Volume (1 week) | 407.69k |
Average Volume (1 Month) | 454.19k |
52 Week Change | -37.83% |
52 Week High | 1.95 |
52 Week Low | 0.6174 |
Spread (Intraday) | 0 (0.29%) |
Company Name | Karyopharm Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.karyopharm.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.